EVAXION A/S (EVAX:NASDAQ)
$4.5 0.01 (0.2227%)
Analysed EVAXION A/S (EVAX:NASDAQ) News Sources
European Equities Traded in the US as American Depositary Receipts Sharply Lower in Tuesday Trading
21-04-2026
yahoo.com
Evaxion’s AI-Immunology™ platform demonstrates 86% vaccine target precision in phase 2 personalized cancer vaccine trial
17-04-2026
yahoo.com
New data demonstrates the unique scalability of Evaxion’s AI-Immunology™ platform in glioblastoma
17-04-2026
yahoo.com
Evaxion concludes Annual General Meeting
16-04-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Declining in Thursday Trading
16-04-2026
yahoo.com
European Equities Traded in the US as ADRs Rise in Tuesday Trading
14-04-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Start Week on Flat Note in Monday Trading
13-04-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading
09-04-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Surge in Wednesday Trading
08-04-2026
yahoo.com
Evaxion announces last patient visit in one-year extension of phase 2 trial with personalized cancer vaccine EVX-01
07-04-2026
yahoo.com
What is the current price of EVAXION A/S (EVAX:NASDAQ)?
The current price of EVAXION A/S (EVAX:NASDAQ) is $4.5.
EVAXION A/S (EVAX:NASDAQ) absolute price change since previous trading day?
The absolute price change of EVAXION A/S (EVAX:NASDAQ) since the previous trading day is $0.01.
EVAXION A/S (EVAX:NASDAQ) percentage price change since previous trading day?
The percentage price change of EVAXION A/S (EVAX:NASDAQ) since the previous trading day is 0.2227%.
What is the most recent average sentiment score for EVAXION A/S (EVAX:NASDAQ)?
The most recent average sentiment score for EVAXION A/S (EVAX:NASDAQ) is 46 out of 100.
What is the most recent average sentiment for EVAXION A/S (EVAX:NASDAQ)?
The most recent sentiment for EVAXION A/S (EVAX:NASDAQ) is .
SEC-8K** Filing Available For EVAXION A/S (EVAX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.